<unk>  is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%.
Vericiguat
Riociguat
Bosentan
Ambrisentan
Sitaxentan
Colestilan
Darusentan
Macitentan